Gene therapy strategy may ease dyskinesia in Parksinson's

Gene therapy strategy may ease dyskinesia in Parksinson's

Levodopa, a standard treatment for Parkinson’s disease, can cause uncontrolled movements called dyskinesia — and this side effect may be driven by changes in a specific receptor component in certain brain cells, a new study shows. Scientists found that an experimental gene therapy strategy aimed at decreasing levels of this receptor component in those specific brain cells could blunt dyskinesia’s development and substantially ease established dy…